View on Pubmed.gov 34478742 | View on doi.org 10.1053/j.gastr...
The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.
- Laboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
- Laboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Anhui Medical University, Hefei, Anhui, China.
- Department of Pathology, The University of Chicago, Chicago, Illinois.
- Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
- Institute of Genetics, University of Bonn, Bonn, Germany.
- Department of Internal Medicine, Yale University, New Haven, Connecticut.
- Laboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Pathology, The University of Chicago, Chicago, Illinois. Electronic address: jrturner@bwh.harvard.edu.
Abstract
BACKGROUNDS & AIMS
Increased permeability is implicated in the pathogenesis of intestinal disease. In vitro and in vivo studies have linked down-regulation of the scaffolding protein ZO-1, encoded by the TJP1 gene, to increased tight junction permeability. This has not, however, been tested in vivo. Here, we assessed the contributions of ZO-1 to in vivo epithelial barrier function and mucosal homeostasis.
METHODS
Public Gene Expression Omnibus data sets and biopsy specimens from patients with inflammatory bowel disease (IBD) and healthy control individuals were analyzed. Tjp1;vil-Cre mice with intestinal epithelial-specific ZO-1 knockout (ZO-1) mice and Tjp1 mice littermates without Cre expression were studied using chemical and immune-mediated models of disease as well as colonic stem cell cultures.
RESULTS
ZO-1 transcript and protein expression were reduced in biopsy specimens from patients with IBD. Despite mildly increased intestinal permeability, ZO-1 mice were healthy and did not develop spontaneous disease. ZO-1 mice were, however, hypersensitive to mucosal insults and displayed defective repair. Furthermore, ZO-1-deficient colonic epithelia failed to up-regulate proliferation in response to damage in vivo or Wnt signaling in vitro. ZO-1 was associated with centrioles in interphase cells and mitotic spindle poles during division. In the absence of ZO-1, mitotic spindles failed to correctly orient, resulting in mitotic catastrophe and abortive proliferation. ZO-1 is, therefore, critical for up-regulation of epithelial proliferation and successful completion of mitosis.
CONCLUSIONS
ZO-1 makes critical, tight junction-independent contributions to Wnt signaling and mitotic spindle orientation. As a result, ZO-1 is essential for mucosal repair. We speculate that ZO-1 down-regulation may be one cause of ineffective mucosal healing in patients with IBD.
References
Cell Host Microbe. 2017 Jun 14;21(6):671-681.e4
Cell Rep. 2020 Feb 4;30(5):1447-1462.e5
Stem Cells. 2012 Sep;30(9):1885-900
Gastroenterology. 2019 Nov;157(5):1323-1337
Cited by 316 citations (total)
Journal Article Research Support, N.I.H., Extramural
Perfluorooctane Sulfonic Acid Disrupts Protective Tight Junction Proteins via Protein Kinase D in Airway Epithelial Cells.
Electronic publication date November 30, 2022
Joseph H Lucas [...] Irfan Rahman et al.
Perfluorooctane sulfonic acid (PFOS) is a long chain per- and polyfluoroalklyl substance (PFAS) that has been used in aqueous film-forming...
Journal Article
Matrix metalloproteinase-7 and claudin-7 as novel identified therapeutic targets for restoration of intestinal epithelial barrier in inflammatory bowel diseases.
Electronic publication date February 1, 2024
Sunisa Hankan [...] Pawin Pongkorpsakol et al.
Intestinal tight junction disruption and mucosal immune dysregulation contribute to pathogenesis and progression of inflammatory bowel diseases (IBD). A proteolytic...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
Copyright
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.